从分子动力学模拟中理解抑制机制,模拟多种类黄和依赖质子的葡萄糖载体之间的相互作用
Xianyang Zeng1, Risong Na2, Lianjuan Yang3
1School of Chemistry, Institute of Theoretical Chemistry, Jilin University, Changchun, China.
Journal of biomolecular structure & dynamics
|December 12, 2023
概括
黄类抑制剂通过与葡萄糖部位结合来阻断葡萄糖载体,在质子状态下表现出更好的疗效. 非抑制剂无法结合,这凸显了药物开发中占用场所的重要性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 质子依赖的葡萄糖载体是药物点的关键因其pH依赖的质子和形态状态.
- 了解这些载体的抑制机制对于开发有效的治疗方法至关重要.
研究的目的:
- 为了研究古典的黄类分子在葡萄糖输送器上的抑制机制.
- 阐明pH值和质子化状态在黄类物质的载体抑制中的作用.
主要方法:
- 用分子动力学模拟来研究葡萄糖载体和选定的黄类抑制剂/非抑制剂之间的相互作用.
- 在两个不同的环境pH条件下进行模拟,以评估质子化状态的影响.
主要成果:
- 黄类抑制剂 (Phloretin,Naringenin,Resveratrol) 成功占领葡萄糖结合位点 (GLN137,ILE255,ASN256),通过其核心部分 (C6-Cn-C6) 形成强烈的疏水相互作用.
- 抑制剂在它们的质子化状态下表现出增强的疗效.
- 非抑制剂 (Isoliquiritigenin,Butein) 不占用葡萄糖结合部位,并显示较弱的蛋白质相互作用.
结论:
- 有效的葡萄糖载体抑制剂必须有效地占据葡萄糖结合部位 (GLN137,ILE255,ASN256) 并限制蛋白质构造变化.
- 质子化状态显著影响着黄类药物对葡萄糖载体的抑制活性.
相关概念视频
Glucose Absorption Into the Small Intestine
31.7K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.7K
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
179
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
179
Enzyme Inhibition
78.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.4K
Secondary Active Transport
7.1K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.1K
Dipeptidyl Peptidase 4 Inhibitors
190
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
190


